{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:42:40Z","timestamp":1783629760221,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.atherosclerosis.2006.07.014","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T11:16:35Z","timestamp":1158146195000},"page":"253-258","source":"Crossref","is-referenced-by-count":43,"title":["Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush"],"prefix":"10.1016","volume":"192","author":[{"given":"C. Daniel","family":"Meyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaijinath S.","family":"Kamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti L.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","article-title":"Influence of nicotinic acid on serum cholesterol in man","volume":"54","author":"Altschul","year":"1955","journal-title":"Arch Biochem"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","article-title":"Niacin therapy in atherosclerosis","volume":"15","author":"Meyers","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7326\/0003-4819-139-12-200312160-00009","article-title":"Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia","volume":"139","author":"Meyers","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/clpt.1991.104","article-title":"Tolerance to nicotinic acid flushing","volume":"50","author":"Stern","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/0003-4819-121-4-199408150-00003","article-title":"Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans","volume":"121","author":"Gray","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib10","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.143.9.2982","article-title":"The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues","volume":"143","author":"Urade","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib11","doi-asserted-by":"crossref","first-page":"18910","DOI":"10.1074\/jbc.270.32.18910","article-title":"Molecular cloning and characterization of the human prostanoid DP receptor","volume":"270","author":"Boie","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib12","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-1-4899-1813-0_73","article-title":"Formation of eicosanoids during differentiation of THP-1 cells","volume":"407","author":"Schwende","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s102380300010","article-title":"Human peritoneal macrophages in culture: a model for studying inflammatory disorders in vitro","volume":"3","author":"Faust","year":"2003","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0026-0495(92)90170-F","article-title":"Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?","volume":"41","author":"Stern","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1006\/bbrc.1996.1269","article-title":"Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages","volume":"225","author":"Barrios-Rodiles","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1525-1497.1997.07118.x","article-title":"Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions","volume":"12","author":"Jungnickel","year":"1997","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","article-title":"Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin","volume":"67","author":"Rubic","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1172\/JCI19796","article-title":"15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?","volume":"112","author":"Powell","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bcp.2005.11.019","article-title":"Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways","volume":"71","author":"Knowles","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2006.04.051","article-title":"Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A","author":"Tang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib22","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Benyo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.0022-202X.2004.23427.x","article-title":"Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis","volume":"123","author":"Dupasquier","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib24","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.151.8.4067","article-title":"Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells","volume":"158","author":"Meunier","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2006.07.014_bib25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0026-0495(64)90034-4","article-title":"Studies on the relation between mobilization of free fatty acids and energy metabolism in man: effects of norepinephrine and nicotinic acid","volume":"13","author":"Havel","year":"1964","journal-title":"Metabolism"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006004126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006004126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T20:51:44Z","timestamp":1683579104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006004126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0021915006004126"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.07.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}